Source: Eur Respir J 2014; 43: 912-914
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Heresi Gustavo A., Aytekin Metin, Hammel Jeffrey P., Wang Sihe, Chatterjee Soumya, Dweik Raed A.. Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension. Eur Respir J 2014; 43: 912-914

Member's Comments

No comment yet.

Related content which might interest you: Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012 Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension? Source: Eur Respir J 2016; 48: 1265-1267 Year: 2016 Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension Source: Eur Respir J, 55 (4) 1901761; 10.1183/13993003.01761-2019 Year: 2020 Analysis of the cardiac index-PvO2 relationship during vasodilatation challenge as a prognostic factor in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Growth-differentiation factor-15 as a prognostic indicator in idiopathic pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Determinants and prognostic value of kidney disease in pulmonary arterial hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Serum levels of vascular endothelial growth factor in patients with systemic sclerosis. Correlation with systolic pressure in the pulmonary artery Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Circulating angiopoietins in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 P-selectin and PDGF serum levels might not be related to idiopathic pulmonary arterial hypertension and schistosomiasis Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension and their relationship with right ventricular structure and function Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Serum and pulmonary uric acid in pulmonary arterial hypertension Source: Eur Respir J, 58 (2) 2000332; 10.1183/13993003.00332-2020 Year: 2021 Neutrophil- to-lymphocyte ratio as a prognostic parameter in pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension Source: Eur Respir J 2014; 44: 704-713 Year: 2014 The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension Source: ERJ Open Res, 7 (4) 00378-2021; 10.1183/23120541.00378-2021 Year: 2021 Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 The role of the biomarker and the genetic polymorphism of endothelin-1 in pulmonary arterial hypertension among Egyptians Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013